"LM_ID","COMMON_NAME","SYSTEMATIC_NAME","FORMULA","MASS","CATEGORY","MAIN_CLASS","SUB_CLASS","CLASS_LEVEL4","SYNONYMS","INCHI_KEY","INCHI","SMILES","KEGG_ID","HMDBID","CHEBI_ID","ABBREVIATION","PUBCHEM_COMPOUND_ID","LIPIDBANK_ID","SWISSLIPIDS_ID","CAYMAN_ID","ALT_CATEGORIES","ALT_MAIN_CLASSES","ALT_SUB_CLASSES","ALT_CLASS_LEVEL4S","TAXONOMY","CITATION"
"LMSP0505AQ07","type II A antigen(d18:1/24:1(15Z))","GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))","C96H170N4O42","2051.128978","Sphingolipids [SP]","Neutral glycosphingolipids [SP05]","Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]","-","-","YWQHZRUZLLILNH-OMBGEIHRSA-N","InChI=1S/C96H170N4O42/c1-7-9-11-13-15-17-19-21-22-23-24-25-26-27-28-30-32-34-36-38-40-42-64(112)100-55(56(111)41-39-37-35-33-31-29-20-18-16-14-12-10-8-2)50-127-92-79(124)77(122)84(63(49-107)135-92)137-95-81(126)86(71(116)59(45-103)131-95)140-90-66(98-53(5)109)74(119)82(61(47-105)133-90)136-94-80(125)85(70(115)58(44-102)130-94)139-91-67(99-54(6)110)75(120)83(62(48-106)134-91)138-96-88(142-93-78(123)76(121)68(113)51(3)128-93)87(72(117)60(46-104)132-96)141-89-65(97-52(4)108)73(118)69(114)57(43-101)129-89/h21-22,39,41,51,55-63,65-96,101-107,111,113-126H,7-20,23-38,40,42-50H2,1-6H3,(H,97,108)(H,98,109)(H,99,110)(H,100,112)/b22-21-,41-39+/t51-,55+,56-,57-,58-,59-,60-,61-,62-,63-,65-,66-,67-,68-,69+,70+,71+,72+,73-,74-,75-,76-,77-,78+,79-,80-,81-,82-,83-,84-,85+,86+,87+,88-,89-,90+,91+,92-,93-,94+,95+,96+/m1/s1","[C@](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@H]7O[C@H](CO)[C@H](O)[C@H](O)[C@H]7NC(=O)C)[C@H]6O[C@H]6O[C@H](C)[C@@H](O)[C@@H](O)[C@@H]6O)[C@H](O)[C@H]5NC(=O)C)[C@H]4O)[C@H](O)[C@H]3NC(=O)C)[C@H]2O)[C@H](O)[C@H]1O)([H])(NC(CCCCCCCCCCCCC/C=C\CCCCCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC","-","-","-","Hex(4)-HexNAc(3)-Fuc-Cer 42:2;O2","44261106","-","-","-","-","-","-","-","-","-"